Discount Vitamins & Herbs

   
- Products by Category
- Alphabetic Product Listing

Home Go Shopping Specials Product Info Health News FAQs About Us Links Site Map

Hyaluronic Acid Center, Neptune Krill Oil & Rejuvenation Science for Doctors

Wednesday, November 28, 2007

Immune System Can Stop Cancer Growth

A multinational team of researchers has shown that the immune system can stop the growth of a cancerous tumor without actually killing it.

When the cancer can't be killed with immune attacks, it may be possible to find ways to use the immune system to contain it. The results also may help explain why some tumors seem to suddenly stop growing and go into a lasting period of dormancy.

The study's authors call the cancer-immune system stalemate equilibrium. During equilibrium, the immune system both decreases the cancer's drive to replicate and kills some of the cancerous cells, but not quickly enough to eliminate or shrink the tumor.

View details on this immune system cancer growth study.

Tuesday, November 27, 2007

Dermatologist Recommended Hair Care

For most people, and especially women, hair is their crowning glory that defines a significant part of their appearance and personal style. Yet, despite its delicate composition, hair is routinely subjected to significant damage from styling products, hair dyes, straightening or waving procedures and even sun exposure. Over time, hair that was once radiant can look brittle, frizzy and lackluster.

Speaking at the American Academy of Dermatology’s SKIN academy, dermatologist Zoe D. Draelos, MD, FAAD, discussed the most common causes of hair damage, including how to prevent it and ways to maintain healthy hair as we age.

“It’s important to understand that hair is nonliving and cannot be repaired once it is injured,” said Dr. Draelos. “As we get older, hair growth slows down and the cosmetic beauty of our hair decreases. The key is to prevent hair loss by stopping the cycle of over-processing and over-grooming our hair and selecting hair care products with proven hair-health benefits.”

See My 5 recommendations for healthy hair growth.

View further information on Dermatologist recommendations for hair care.

Friday, November 23, 2007

Vitamin D-3 Reduces Cancer Risk 60%

A landmark study by Lappe and other Creighton researchers, published in June 2007 in the American Journal of Clinical Nutrition, showed a direct link between vitamin D and cancer prevention.

The Canadian Cancer Society recently recommended that people with light skin take 1,000 IU of the vitamin supplement during fall and winter, while people with darker skin or limited sun exposure take that amount throughout the year.

The society’s recommendation coincided with the publication of the Creighton research in June. The four-year study involving 1,179 Nebraska women showed that women taking calcium supplements plus 1,100 IU of vitamin D3 daily, experienced a 60 percent decrease in their risk of developing cancer than a placebo group.

“Generally, medical experts consider it safe to take between 1,000 IU and 2,000 IU of vitamin D supplements daily,” Lappe says.

View details of this Vitamin D-3 cancer reduction study.

Monday, November 19, 2007

Pre-eclampsia Linked to Heart Disease

Two studies, published together on bmj.com, add further weight to the theory that pre-eclampsia and cardiovascular diseases may share common causes or mechanisms.

The first study finds that women who have had pre-eclampsia during pregnancy have a more than two fold higher risk of heart disease in later life, while the second shows that women with cardiovascular risk factors that are present years before pregnancy may be predisposed to pre-eclampsia.

Women with a history of pre-eclampsia also had an almost four fold increased risk of high blood pressure (hypertension) and a two fold increased risk of fatal and non-fatal ischaemic heart disease, stroke, and blood clots (venous thromboembolism) in later life.

Read details on these pre-eclampsia heart disease studies.

Wednesday, November 14, 2007

Predicting Survival After Liver Transplantation

Patients awaiting liver transplantation who also suffer from coronary disease, diabetes, chronic obstructive pulmonary disease (COPD), connective tissue disease or renal insufficiency may face poorer survival after liver transplantation. These conditions have been incorporated into a new modified comorbidity index which helps predict post-transplant survival.

Forty percent of the patients had one or more comorbidities prior to transplantation. After statistical analysis, the researchers found that coronary disease, diabetes, COPD, connective tissue disease, and renal insufficiency were all independent predictors of poorer post-transplant survival.

Read details on this post-liver transplantation survival prediction study.

Tuesday, November 13, 2007

Study Projects 60 Percent Increase In ESRD Population By 2020

Researchers predict sharp increases in the U.S. incidence and prevalence of end-stage renal disease (ESRD) in the years ahead. "The expected number of patients with ESRD in 2020 is almost 785,000, which is an increase of over 60 percent compared to 2005."

"These projections play an important role in shaping public health policy and health care planning related to the treatment of kidney disease," says Dr. Gilbertson. "Medicare pays for the care for the vast majority of patients with ESRD, with costs approaching $60,000 per year for every patient."

See also: 81% Positive Response to Coenzyme Q10 Treatment for Chronic Kidney Failure

View details on this end stage renal disease study.

Saturday, November 10, 2007

Aging Heart Changes Shape, Shrinks and Loses Pumping Function

Researchers found that each year as people age, the time it takes for their heart muscles to squeeze and relax grows longer, by 2 percent to 5 percent. The findings, researchers say, offer insight into the root causes of heart failure.

Another inflammatory marker C-reactive protein has also been linked to the development of ischaemic heart disease in previous studies. Omega-3 fish oil and krill oil have been shown to reduce c-reactive protein 30% over a 3-month period.

Read details on this aging heart function study.

Friday, November 02, 2007

Funding Source Bias Regarding Adverse Effects

Studies of inhaled corticosteroids, medications frequently prescribed for asthma and other respiratory problems, appear less likely to find adverse effects if they are funded by pharmaceutical companies than if they are funded by other sources.

Their use has been associated with potentially harmful decreases in the stress hormone cortisol, decreases in bone mineral density and growth suppression.

Overall, 34.5 percent of pharmaceutical-funded studies and 65.1 percent of studies with other funding sources found a significant difference in adverse effects between individuals assigned to inhaled corticosteroid groups and those who were not.

Read details of this funding source adverse effects bias study.